- Home
- GMM vs PMVP Comparison
GMM vs PMVP Comparison
Compare GMM & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GMM
- PMVP
- Stock Information
- Founded
- GMM 2017
- PMVP 2013
- Country
- GMM China
- PMVP United States
- Employees
- GMM N/A
- PMVP N/A
- Industry
- GMM
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- GMM
- PMVP Health Care
- Exchange
- GMM Nasdaq
- PMVP Nasdaq
- Market Cap
- GMM 70.8M
- PMVP 71.9M
- IPO Year
- GMM 2023
- PMVP 2020
- Fundamental
- Price
- GMM $3.44
- PMVP $1.02
- Analyst Decision
- GMM
- PMVP Strong Buy
- Analyst Count
- GMM 0
- PMVP 3
- Target Price
- GMM N/A
- PMVP $5.33
- AVG Volume (30 Days)
- GMM 33.8K
- PMVP 103.3K
- Earning Date
- GMM 05-16-2025
- PMVP 03-03-2025
- Dividend Yield
- GMM N/A
- PMVP N/A
- EPS Growth
- GMM 62.17
- PMVP N/A
- EPS
- GMM 6.37
- PMVP N/A
- Revenue
- GMM $41,360,953.00
- PMVP N/A
- Revenue This Year
- GMM N/A
- PMVP N/A
- Revenue Next Year
- GMM N/A
- PMVP N/A
- P/E Ratio
- GMM $0.52
- PMVP N/A
- Revenue Growth
- GMM 53.82
- PMVP N/A
- 52 Week Low
- GMM $0.21
- PMVP $0.96
- 52 Week High
- GMM $4.97
- PMVP $2.26
- Technical
- Relative Strength Index (RSI)
- GMM 40.26
- PMVP 20.23
- Support Level
- GMM $3.00
- PMVP $1.21
- Resistance Level
- GMM $4.21
- PMVP $1.18
- Average True Range (ATR)
- GMM 0.45
- PMVP 0.06
- MACD
- GMM -0.08
- PMVP -0.02
- Stochastic Oscillator
- GMM 25.14
- PMVP 0.00
About GMM Global Mofy Metaverse Limited
Global Mofy AI Ltd operates as a technology solutions provider engaged in virtual content production, digital marketing, and digital assets development for the metaverse industry. It utilizes its proprietary Mofy Lab technology platform which consists of three-dimensional (3D) rebuilt technology and artificial intelligence (AI) interactive technology to create a 3D high-definition virtual version of a wide range of physical world objects such as human, animal, and scenes which can be used in different applications.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.